Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 631 * ! | Thu, 8/8/2013, 8:30 AM - 10:20 AM | CC-511d | |
| Recent Advances in Methodology for CNS Clinical Trials — Topic Contributed Papers | |||
| Biopharmaceutical Section , Mental Health Statistics Section , Biometrics Section | |||
| Organizer(s): Pilar Lim, PhD, Janssen Research and Development LLC | |||
| Chair(s): H. M. James Hung, PhD, U. S. Food and Drug Administration | |||
| 8:35 AM | Assessing Impairment Risk Produced by Use of a CNS Drug When Normal Ranges Are Uncertain — Eugene Laska, Nathan Kline Institute, NYU School of Medicine | ||
| 8:55 AM | Interim Monitoring of Longitudinal Outcomes in Clinical Trials — Michael McDermott, Univ of Rochester Medical Center ; Xueya Cai, Univ of Rochester Medical Center | ||
| 9:15 AM | Recent Advances in Design and Methodology in Psychiatric Clinical Trials — Peiling Yang, Food and Drug Administration | ||
| 9:35 AM | Study Designs and Ability to Deal with Missing Data and Yield Interpretations — Ralph D'Agostino, Sr., Boston University | ||
| 9:55 AM | Fisherian Evidential Approach for Adaptive Doubly Randomized Withdrawal Designs — Qing Liu, Johnson & Johnson | ||
| 10:15 AM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.